Publication of the masitinib positive pivotal phase 3 trial in progressive forms of multiple sclerosis in the journal Neurology® Neuroimmunology & Neuroinflammation
22/02/2022 – AB Science announced the publication of results from its positive pivotal phase 3 trial of masitinib in progressive forms of multiple sclerosis in the peer-reviewed journal Neurology® Neuroimmunology & Neuroinflammation